Andrew Barleben (@andrewbarleben) 's Twitter Profile
Andrew Barleben

@andrewbarleben

Associate Professor Vascular and Endovascular Surgery UCSD, opinions are my own.

ID: 1087798640750424064

calendar_today22-01-2019 19:46:21

419 Tweet

204 Takipçi

206 Takip Edilen

Gustavo Oderich (@gustavooderich) 's Twitter Profile Photo

Fresh from #asa23 in Toronto #FBEVAR in 2,603 #TAAA patients with mortality of 4.5% for elective and 17% for non-elective procedures. Risk of aortic death 9% in 5yrs. Next steps: how to reduce reintervention and cost?

Fresh from #asa23 in Toronto #FBEVAR in 2,603 #TAAA patients with mortality of 4.5% for elective and 17% for non-elective procedures. Risk of aortic death 9% in 5yrs. Next steps: how to reduce reintervention and cost?
Athanasios Saratzis (@a_saratzis) 's Twitter Profile Photo

BASIL2 RCT paper now available on The Lancet Endovascular strategy superior for BTK lesions in terms of amputation free survival. thelancet.com/journals/lance…

Andrew Barleben (@andrewbarleben) 's Twitter Profile Photo

Congratulations and great work to Rohini Patel and @fallentineMS4 (who won’t be an MS4 forever) on their great presentations! Representing UC San Diego Surgery at SoCal Vascular!!! #scvss #scvss2023

Congratulations and great work to Rohini Patel and @fallentineMS4 (who won’t be an MS4 forever) on their great presentations! Representing <a href="/UCSDsurgery/">UC San Diego Surgery</a> at <a href="/VascularSocal/">SoCal Vascular</a>!!! #scvss #scvss2023
Matthias Siepe (@matthiassiepe) 's Twitter Profile Photo

70 years ago (May 6, 1953), Dr. John Gibbon used a heart-lung machine for the first time on an 18-year-old female ASD patient. A well-prepared giant achievement and the very begin of modern cardiac surgery! It also may remind us to foster innovation and allow disruptive ideas.

70 years ago (May 6, 1953), Dr. John Gibbon used a heart-lung machine for the first time on an 18-year-old female ASD patient. A well-prepared giant achievement and the very begin of modern cardiac surgery! It also may remind us to foster innovation and allow disruptive ideas.
Grayson Wheatley (@drwheatley) 's Twitter Profile Photo

Apple Watch helps save woman’s life after collapsing in a hotel room from a ruptured aorta #aorticaneurysm 9to5mac.com/2023/05/05/app…

Firas F Mussa (@untbad) 's Twitter Profile Photo

To everyone who will be at #VAM23 if you treat TBAD and have an opinion, idea, input, criticism, concern, question or just for “the love of the game”…join us next Friday 🙏 Panos Kougias MD MSc @ShereneShalhub Vascular SVS Michael S. Conte, MD

To everyone who will be at #VAM23 if you treat TBAD and have an opinion, idea, input, criticism, concern, question or just for “the love of the game”…join us next Friday 🙏 <a href="/KougiasP/">Panos Kougias MD MSc</a> @ShereneShalhub <a href="/VascularSVS/">Vascular SVS</a> <a href="/MichaelSConteMD/">Michael S. Conte, MD</a>
ᗰIGᑌEᒪ ᗰOᑎTEᖇO-ᗷᗩKEᖇ (@monteromiguel) 's Twitter Profile Photo

Fresh off the press. Our #HOPE team was invited to put together a step by step review of arterialization techniques. Open and endo are complimentary and each have their place. Read and share 🙏 doi.org/10.1016/j.jvsc… Jill Sommerset Matthew Smeds Hendolat Vascupedia

Gustavo Oderich (@gustavooderich) 's Twitter Profile Photo

The Cook ZFEN+ IDE is approved by the FDA to start trial. Finally a tailored, patient specific fenestrated stent-graft to repair complex aortic aneurysms with more sealing, less compromise on vessel incorporation. It will expand indications of EVAR significantly!

The Cook ZFEN+ IDE is approved by the FDA to start trial. Finally a tailored, patient specific fenestrated stent-graft to repair complex aortic aneurysms with more sealing, less compromise on vessel incorporation. It will expand indications of EVAR significantly!
UCSF Vascular Surgery (@ucsfvascular) 's Twitter Profile Photo

📢Have you registered for the 2023 UCSF Vascular Symposium yet? Visit our website to register and view the fast-paced program including debates, interactive case discussions, and expert panels with an outstanding multi-disciplinary faculty. vascularsymposium.ucsf.edu

Sean Lyden (@drseanlyden) 's Twitter Profile Photo

UPDATE: Risk of Mortality Associated with Paclitaxel-Coated Devices to Treat Peripheral Arterial Disease is No Longer Supported Based on Data and Analyses - Letter to Health Care Providers fda.gov/medical-device…

CircInterventions (@circintv) 's Twitter Profile Photo

Ingenuity in the Cath Lab. Endovascular Aortic Root Repair (Endo-Bentall) for Acute Type A Dissection. ahajournals.org/doi/abs/10.116… Shahab Mehrdad Ghoreishi #TAVR #TEVAR #Cardiotwitter #AHAJournals

Ingenuity in the Cath Lab. Endovascular Aortic Root Repair (Endo-Bentall) for Acute Type A Dissection. ahajournals.org/doi/abs/10.116… <a href="/Toursavadkohi/">Shahab</a> <a href="/dr_ghoreishi/">Mehrdad Ghoreishi</a> #TAVR #TEVAR #Cardiotwitter #AHAJournals
Vascular News (@vascularnews) 's Twitter Profile Photo

Roger Malcolm Greenhalgh, the surgeon internationally renowned for his unparalleled contribution to vascular education, training and research, died peacefully on 6th October, aged 82. Read the full Obituary here: vascularnews.com/obituary-roger…

Roger Malcolm Greenhalgh, the surgeon internationally renowned for his unparalleled contribution to vascular education, training and research, died peacefully on 6th October, aged 82.

Read the full Obituary here: vascularnews.com/obituary-roger…